Great to see winners of the @LPDementia in the Washington Post
Stay tuned over the coming days as we announce the 20 world-class @longitude_prize on ALS teams! They will now deploy #AI on the largest disease data set of its kind to tackle #ALS.
Great to see @krakenfx one of our dynamic demand prize finalists go from idea to a $9bn valuation! @challengeworks theguardian.com/business/202…
trisdyson retweeted
@OHENews estimates that eradicating ALS could deliver $143B+ in value over 10 years. The potential global value is huge. #ALS/#MND remains underfunded and breakthroughs are urgently needed.
Full report: lnkd.in/e3-DMaiB
Learn more about the Prize bit.ly/4nyp6nq
trisdyson retweeted
Calling all AI and biotech innovators and researchers across India: applications for the Longitude Prize on ALS close on 3 December, and we’re looking for you: als.longitudeprize.org/
See @Taslimarif's latest piece for @DeccanHerald (@CCAMP_India) here bit.ly/4paLBQn
"The steps the country takes now could shape its ability to respond in the future."
In his latest opinion piece for @DeccanHerald, CCAMP Director-CEO @Taslimarif reflects on India’s AI-based drug discovery, research into diseases of ageing, and the impact of the Longitude Prize on ALS.
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects motor neurons, causing the brain to gradually lose its ability to control muscles and impacting mobility, speech, and breathing. It affects approximately 2–3 people per 100,000 individuals worldwide.
Read now: deccanherald.com/opinion/har…
Dr. Taslimarif Saiyed is a jury member on the @longitude_prize, the £7.5M global challenge for ALS treatment technologies.
Apply now: als.longitudeprize.org/
@DrJitendraSingh @DBTIndia @rajesh_gokhale @IndiaDST @karandi65 @BIRAC_2012 @AIMtoInnovate @NITIAayog @NIMHANS_BLR @kris_sg @NCBS_Bangalore @DBT_inStem @DBT_NBRC @aiims_newdelhi @aiims_jodhpur @iitmadras @iiscbangalore @startupindia @ITBTGoK @Ktech_biotech @startupindia
trisdyson retweeted
Grateful to John Driskell Hopkins, or “Hop” - from the the Grammy Award–winning @zacbrownband and @HopOnACure - for his support for The Longitude Prize on ALS.
Living with #ALS himself, Hop has campaigned to raise awareness for those affected by this devastating disease.
trisdyson retweeted
There's 1 month left to apply for the £7.5m (~$10m) Longitude Prize on ALS, start your application today bit.ly/4nyp6nq
#AIforGood #ALS #MND #Neuroscience
trisdyson retweeted
We had the pleasure of catching up with @DrBrianDickie MBE, Chief Scientist at the @mndassoc, the principal funder of the £7.5M Longitude Prize on ALS.
📖 Read the full Q&A here: bit.ly/3KTi1Ap
trisdyson retweeted
Join us at the #ASHG25 Annual Meeting in Boston, starting today!
Visit us at Booth 46, we’d love to meet you and discuss how the ~$10M Longitude Prize on ALS is harnessing #AI to transform the future of neurodegenerative disease treatment.
@Challenge_Works @GeneticsSociety
trisdyson retweeted
⏰ 2 months to go until applications close for the £7.5 million Longitude Prize on ALS.
You could help transform treatment for neurodegenerative diseases like hashtag #ALS, the most common form of motor neurone disease (#MND).
Learn more: bit.ly/4mlzSg5
trisdyson retweeted
🚨 1 week to go! Curious about the Longitude Prize on ALS or planning to enter? You won't want to miss this.
Be the first to explore the data powering the Prize with our partners (Project MinE, @AnswerALS, @ALSTDI & ALS Compute).
Register now👇
bit.ly/45tueUe
ALT Register now https://bit.ly/45tueUe
Longitude Prize on ALS Encourages Using AI To Find New Treatments asianscientist.com/2025/07/h…
trisdyson retweeted
The first treatment for a form of #MND/#ALS has been approved in the UK.
#Tofersen is now authorised for SOD1 MND, demonstrating the potential of gene-targeted therapies.
@UKMNDRI RI partners @sheffielduni & @KingsIoPPN contributed to the trials.
ukmndri.org/2025/07/31/first…
trisdyson retweeted
How can #AI transform #ALS drug discovery?
@CarolinePurslow from @Challenge_Works explains why now is the moment for the £7.5M Longitude Prize on ALS — and how AI could help outpace one of medicine’s toughest diseases.
🧠Read more: bit.ly/3IMpGPX
#ALS #MND #AIforGood
trisdyson retweeted
We're proud to partner with @MNDoddie5, a driving force in the fight against #MND & #ALS.
As a funder of the #LongitudePrizeOnALS, they're supporting bold new ideas to transform #DrugDiscovery for one of medicine's toughest challenges.
🔗Learn more: bit.ly/43HIA13
trisdyson retweeted
Tris Dyson’s Mission to Defeat Motor Neurone Disease
As managing director behind the $10 million dollar Longitude Prize for ALS, he’s channeling urgency, optimism, and innovation into solving one of the most brutal neurological diseases on the planet.
podcasts.apple.com/us/podcas…
trisdyson retweeted
“MND is one of the most scientifically and biologically challenging diseases to tackle. That said, no mountain is insurmountable…”
Dr. Mike Rogers (@mndassoc) shares why the #LongitudePrizeOnALS is key to creating opportunities for bright ideas to be seen, heard and developed.
Mike Rogers, MND Association Director of Research and Innovation, looks at how data and AI could unlock new treatments.
longevity.technology/news/cl…
#longevity #ALSresearch #AIforGood #neuroscience #healthtech #ALSawareness #drugdiscovery
trisdyson retweeted
Mike Rogers, MND Association Director of Research and Innovation, looks at how data and AI could unlock new treatments.
longevity.technology/news/cl…
#longevity #ALSresearch #AIforGood #neuroscience #healthtech #ALSawareness #drugdiscovery
trisdyson retweeted
📢 We’ll be at #ISMBECCB2025 in Liverpool!
🧠 Join the Longitude Prize on ALS team at Booth 23 & don’t miss our Tech Talk on the 22nd of July.
🔗Learn more: bit.ly/4kAPpIc
